The impact of histological variants of urothelial carcinoma on clinical outcomes following trimodality bladder-sparing chemoradiation
Over 90% of bladder tumours are urothelial (transitional cell) carcinomas; most of the remainder are pure squamous cell carcinoma (3–5%) and adenocarcinoma (<2%). Invasive urothelial carcinoma (UC) shows diversity in its morphology in pure form, but divergent differentiation is also recognise...
主要な著者: | Kiltie, A, Browning, L |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
Elsevier
2017
|
類似資料
-
Radical cystectomy for bladder urothelial carcinoma with aggressive variant histology
著者:: Vahid Mehrnoush, 等
出版事項: (2022-09-01) -
Induction therapy with ipilimumab and nivolumab followed by consolidative chemoradiation as organ-sparing treatment in urothelial bladder cancer: study protocol of the INDIBLADE trial
著者:: C.F. Stockem, 等
出版事項: (2023-08-01) -
Variant Histology: The Impact on Oncological Outcomes of Patients with Urothelial Carcinoma of The Bladder Treated with Radical Cystectomy
著者:: Berk Hazır, 等
出版事項: (2021-12-01) -
Clinical Outcomes of Patients With Variant Histology of Urothelial Carcinoma After Radical Cystectomy
著者:: Dan Bee Lee, 等
出版事項: (2023-11-01) -
SURVIVAL IN PATIENTS WITH HISTOLOGIC VARIANTS OF UROTHELIAL TYPE BLADDER CANCER
著者:: Richard Hartanto, 等
出版事項: (2024-09-01)